• Markets
  • icon
  • Companies
LGP · ASX

Little Green Pharma Ltd. (ASX:LGP)

AU$0.14

 -0.005 (-3.571%)
ASX:Live
15/04/2024 01:34:08 PM
Hammer Bullish HALO Ords GROWTH AUS Consensus Cheap All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

LGP Overview

LGP Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About LGP

Telephone

Address

Description

Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. Its medicines are cultivated, without pesticides, in a hydroponic facility. The company was founded in 2017 and is headquartered in West Perth, Australia.

LGP Price Chart

Key Stats

Market Cap

AU$39.03M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.12 - 0.21

Trade Value (12mth)

AU$6,512.00

1 week

3.7%

1 month

12%

YTD

-9.68%

1 year

-22.22%

All time high

1.017

Key Fundamentals

EPS 3 yr Growth

-51.000%

EBITDA Margin

-35.20%

Operating Cashflow

-$7m

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

299m

HALO Sector

Next Company Report Date

29-May-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

LGP Announcements

Latest Announcements

Date Announcements

04 April 24

Change of Director's Interest Notice x 2

×

Change of Director's Interest Notice x 2

03 April 24

Application for quotation of securities - LGP

×

Application for quotation of securities - LGP

28 February 24

First Polish Shipment

×

First Polish Shipment

26 February 24

Germany Legalises Cannabis

×

Germany Legalises Cannabis

21 February 24

Results of General Meeting and appointment of auditor

×

Results of General Meeting and appointment of auditor

19 February 24

Reset Offers withdrawn and Reset to remain LGP subsidiary

×

Reset Offers withdrawn and Reset to remain LGP subsidiary

19 February 24

Final Appendix 3A.5

×

Final Appendix 3A.5

08 February 24

Investor Webinar & December Quarterly Results Presentation

×

Investor Webinar & December Quarterly Results Presentation

01 February 24

LGP receives $5 million R&D rebate

×

LGP receives $5 million R&D rebate

31 January 24

Quarterly Activities Report & Appendix 4C

×

Quarterly Activities Report & Appendix 4C

17 January 24

Extension of Reset Offers and change of General Meeting date

×

Extension of Reset Offers and change of General Meeting date

17 January 24

Updated Appendix 3A.5

×

Updated Appendix 3A.5

11 January 24

Reset sponsored WA Psilocybin Clinical Trial Opens

×

Reset sponsored WA Psilocybin Clinical Trial Opens

04 January 24

Reset Offers extension and change of General Meeting date

×

Reset Offers extension and change of General Meeting date

04 January 24

Updated Appendix 3A.5

×

Updated Appendix 3A.5

12 December 23

Updated Appendix 3A.5

×

Updated Appendix 3A.5

11 December 23

Change of date of General Meeting and Reset Offers

×

Change of date of General Meeting and Reset Offers

07 December 23

LGP to capitalise on new French cannabis healthcare laws

×

LGP to capitalise on new French cannabis healthcare laws

30 November 23

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

30 November 23

Half Yearly Financial Presentation

×

Half Yearly Financial Presentation

30 November 23

CEO Update on Financial Results

×

CEO Update on Financial Results

21 November 23

Reset Mind Sciences Investor Webinar

×

Reset Mind Sciences Investor Webinar

20 November 23

Reset Mind Sciences - Investor Presentation

×

Reset Mind Sciences - Investor Presentation

17 November 23

Reset Mind Sciences Offers Open

×

Reset Mind Sciences Offers Open

10 November 23

Correction of Defective Cleansing Notice

×

Correction of Defective Cleansing Notice

LGP Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock N/A -0.10 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock N/A -0.10 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 66.9 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock N/A -0.07 -0.03 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock N/A -0.11 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 61.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A -21.7 N/A Lock Lock Lock
DPS $ Lock Lock Lock Lock N/A 0.00 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock N/A 0 N/A Lock Lock Lock
BPS $ Lock Lock Lock Lock N/A 0.31 N/A Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock N/A 0.31 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock N/A 236 N/A Lock Lock Lock
Basic m Lock Lock Lock Lock N/A 236 N/A Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock N/A 14 20 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 41.4 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock N/A 33 N/A Lock Lock Lock
Gross Income $m Lock Lock Lock Lock N/A 5 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A 32.1 N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A 68 N/A Lock Lock Lock
EBITDA $m Lock Lock Lock Lock N/A -27 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 74.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -192.5 -35.2 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock N/A 1 3 Lock Lock Lock
EBIT $m Lock Lock Lock Lock N/A -28 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -202.1 N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock N/A -27 N/A Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock N/A -3 N/A Lock Lock Lock
Net Income $m Lock Lock Lock Lock N/A -24 -11 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 54.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -171.4 -54.9 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock N/A -17 -7 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock N/A 8 2 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock N/A -8 N/A Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock N/A 5 N/A Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock N/A -25 -21 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 15.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -1.8 -1.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock N/A 20 N/A Lock Lock Lock
Total Assets $m Lock Lock Lock Lock N/A 96 42 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock N/A 4 N/A Lock Lock Lock
Net Debt $m Lock Lock Lock Lock N/A -4 1 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock N/A 20 N/A Lock Lock Lock
Equity $m Lock Lock Lock Lock N/A 75 26 Lock Lock Lock
Invested Capital Lock Lock Lock Lock N/A 79 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock N/A -25.1 -25.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock N/A -31.9 -41.8 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock N/A -53.9 N/A Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock N/A -51.7 N/A Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock N/A -36.9 N/A Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A -37.3 N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock N/A 0.2 -0.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock N/A -5.6 2.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock N/A 2.1 N/A Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock N/A 1.6 N/A Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock N/A 56.7 N/A Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock N/A -103.7 N/A Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock N/A 4.5 N/A Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A 2.0 N/A Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock N/A 0.7 N/A Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A 22.8 N/A Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock N/A 0.1 0.5 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock N/A 0.1 0.5 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A -193.9 N/A Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A -28.4 N/A Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock N/A -25.1 -25.6 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock N/A 1.3 1.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock N/A -31.9 -41.8 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock N/A 100.0 N/A Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock N/A -31.9 N/A Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A 182.9 N/A Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A 81.0 N/A Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A 263.8 N/A Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A 52.1 N/A Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock N/A 211.7 N/A Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

LGP Shortsell

Frequently Asked Questions

The current share price of Little Green Pharma Ltd. (LGP:ASX) is AU$0.14.
The 52-week high share price for Little Green Pharma Ltd. (LGP:ASX) is AU$0.21.
The 52-week low share price for Little Green Pharma Ltd. (LGP:ASX)? is AU$0.12.
Little Green Pharma Ltd. (LGP:ASX) does not pay a dividend.
Little Green Pharma Ltd. (LGP:ASX) does not pay a dividend.
Little Green Pharma Ltd. (LGP:ASX) has a franking level of 0%.
Little Green Pharma Ltd. (LGP:ASX) is classified in the Industrials.
The current P/E ratio for Little Green Pharma Ltd. (LGP:ASX) is .